6.
Mintsa-Nguema R, Zoa-Assoumou S, Mewono L, MBondoukwe N, Essono P, Mengue-Me-Ngou-Milama K
. Could pooled samples method affect SARS-CoV-2 diagnosis accuracy using BGI and Sansure-Biotech RT-PCR kits used in Gabon, Central Africa?. PLoS One. 2022; 17(1):e0262733.
PMC: 8782308.
DOI: 10.1371/journal.pone.0262733.
View
7.
Ravichandran B, Grimm D, Kruger M, Kopp S, Infanger M, Wehland M
. SARS-CoV-2 and hypertension. Physiol Rep. 2021; 9(11):e14800.
PMC: 8198473.
DOI: 10.14814/phy2.14800.
View
8.
Kilic H, Arguder E, Karalezli A, Unsal E, Guner R, Kayaslan B
. Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients. Front Med (Lausanne). 2022; 9:957598.
PMC: 9606396.
DOI: 10.3389/fmed.2022.957598.
View
9.
Landstra C, de Koning E
. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Front Endocrinol (Lausanne). 2021; 12:649525.
PMC: 8247904.
DOI: 10.3389/fendo.2021.649525.
View
10.
Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N
. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J Med Virol. 2020; 92(10):1915-1921.
PMC: 7262275.
DOI: 10.1002/jmv.25889.
View
11.
Oliveira B, de Oliveira L, Sabino E, Okay T
. SARS-CoV-2 and the COVID-19 disease: a mini review on diagnostic methods. Rev Inst Med Trop Sao Paulo. 2020; 62:e44.
PMC: 7325591.
DOI: 10.1590/S1678-9946202062044.
View
12.
Jin J, Bai P, He W, Wu F, Liu X, Han D
. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020; 8:152.
PMC: 7201103.
DOI: 10.3389/fpubh.2020.00152.
View
13.
Geca T, Wojtowicz K, Guzik P, Gora T
. Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention. Int J Environ Res Public Health. 2022; 19(11).
PMC: 9180541.
DOI: 10.3390/ijerph19116555.
View
14.
Ghanei M, Mohabattalab A, Fartash K, Kolahchi N, Khakdaman A, Kaghazian H
. Exploring the experience of developing COVID-19 vaccines in Iran. Clin Exp Vaccine Res. 2023; 12(1):1-12.
PMC: 9950226.
DOI: 10.7774/cevr.2023.12.1.1.
View
15.
Gerayeli F, Milne S, Cheung C, Li X, Yang C, Tam A
. COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine. 2021; 33:100789.
PMC: 7971471.
DOI: 10.1016/j.eclinm.2021.100789.
View
16.
Ahmad F, Cisewski J, Xu J, Anderson R
. COVID-19 Mortality Update - United States, 2022. MMWR Morb Mortal Wkly Rep. 2023; 72(18):493-496.
PMC: 10168601.
DOI: 10.15585/mmwr.mm7218a4.
View
17.
Gulsen A, Konig I, Jappe U, Dromann D
. Effect of comorbid pulmonary disease on the severity of COVID-19: A systematic review and meta-analysis. Respirology. 2021; 26(6):552-565.
PMC: 8207055.
DOI: 10.1111/resp.14049.
View
18.
Sahni S, Gupta G, Sarda R, Pandey S, Pandey R, Sinha S
. Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis. Diabetes Metab Syndr. 2021; 15(6):102308.
PMC: 8492383.
DOI: 10.1016/j.dsx.2021.102308.
View
19.
Li S, Ren J, Hou H, Han X, Xu J, Duan G
. The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates. Neurol Sci. 2022; 43(7):4049-4059.
PMC: 8943353.
DOI: 10.1007/s10072-022-06024-9.
View
20.
Goldstein J, Lee R
. Demographic perspectives on the mortality of COVID-19 and other epidemics. Proc Natl Acad Sci U S A. 2020; 117(36):22035-22041.
PMC: 7486771.
DOI: 10.1073/pnas.2006392117.
View